Metal ions, pH, and cholesterol regulate the interactions of Alzheimer's disease amyloid-β peptide with membrane lipid

被引:180
|
作者
Curtain, CC
Ali, FE
Smith, DG
Bush, AI
Masters, CL
Barnham, KJ [1 ]
机构
[1] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia
[2] Mental Hlth Res Int Victoria, Parkville, Vic 3052, Australia
[3] Monash Univ, Sch Phys & Mat Engn, Clayton, Vic 3800, Australia
[4] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia
[5] Harvard Univ, Massachusetts Gen Hosp East, Sch Med, Lab Oxidat Biol, Charlestown, MA 02129 USA
[6] Harvard Univ, Massachusetts Gen Hosp East, Sch Med, Aging Res Unit, Charlestown, MA 02129 USA
[7] Harvard Univ, Massachusetts Gen Hosp East, Sch Med, Dept Psychiat, Charlestown, MA 02129 USA
关键词
D O I
10.1074/jbc.M205455200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of Abeta peptides with the lipid matrix of neuronal cell membranes plays an important role in the pathogenesis of Alzheimer's disease. By using EPR and CD spectroscopy, we found that in the presence of Cu2+ or Zn2+, pH, cholesterol, and the length of the peptide chain influenced the interaction of these peptides with lipid bilayers. In the presence of Zn2+, Abeta40 and Abeta42 both inserted into the bilayer over the pH range 5.5-7.5, as did Abeta42 in the presence of Cu2+. However, Abeta40 only penetrated the lipid bilayer in the presence of Cu2+ at pH 5.5-6.5; at higher pH there was a change in the Cu2+ coordination sphere that inhibited membrane insertion. In the absence of the metals, insertion of both peptides only occurred at pH < 5.5. Raising cholesterol to 0.2 mol fraction of the total lipid inhibited insertion of both peptides under all conditions investigated. Membrane insertion was accompanied by the formation of alpha-helical structures. The nature of these structures was the same irrespective of the conditions used, indicating a single low energy structure for Abeta in membranes. Peptides that did not insert into the membrane formed beta-sheet structures on the surface of the lipid.
引用
收藏
页码:2977 / 2982
页数:6
相关论文
共 50 条
  • [41] Intracellular amyloid-β in Alzheimer's disease
    LaFerla, Frank M.
    Green, Kim N.
    Oddo, Salvatore
    NATURE REVIEWS NEUROSCIENCE, 2007, 8 (07) : 499 - 509
  • [42] Amyloid-β Immunotherapy for Alzheimer's Disease
    Fu, H. J.
    Liu, B.
    Frost, J. L.
    Lemere, C. A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (02) : 197 - 206
  • [43] Amyloid-β hypothesis of Alzheimer's disease
    Shearman, MS
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 187 - 190
  • [44] The Amyloid-β Pathway in Alzheimer's Disease
    Hampel, Harald
    Hardy, John
    Blennow, Kaj
    Chen, Christopher
    Perry, George
    Kim, Seung Hyun
    Villemagne, Victor L.
    Aisen, Paul
    Vendruscolo, Michele
    Iwatsubo, Takeshi
    Masters, Colin L.
    Cho, Min
    Lannfelt, Lars
    Cummings, Jeffrey L.
    Vergallo, Andrea
    MOLECULAR PSYCHIATRY, 2021, 26 (10) : 5481 - 5503
  • [45] The Amyloid-β Pathway in Alzheimer’s Disease
    Harald Hampel
    John Hardy
    Kaj Blennow
    Christopher Chen
    George Perry
    Seung Hyun Kim
    Victor L. Villemagne
    Paul Aisen
    Michele Vendruscolo
    Takeshi Iwatsubo
    Colin L. Masters
    Min Cho
    Lars Lannfelt
    Jeffrey L. Cummings
    Andrea Vergallo
    Molecular Psychiatry, 2021, 26 : 5481 - 5503
  • [46] Metals and amyloid-β in Alzheimer's disease
    Maynard, CJ
    Bush, AI
    Masters, CL
    Cappai, R
    Li, QX
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2005, 86 (03) : 147 - 159
  • [47] Amyloid-β immunisation for Alzheimer's disease
    Wisniewski, Thomas
    Konietzko, Uwe
    LANCET NEUROLOGY, 2008, 7 (09): : 805 - 811
  • [48] Intracellular amyloid-β in Alzheimer's disease
    Frank M. LaFerla
    Kim N. Green
    Salvatore Oddo
    Nature Reviews Neuroscience, 2007, 8 : 499 - 509
  • [49] Autoantibodies to amyloid-β and Alzheimer's disease
    Hyman, BT
    Smith, C
    Buldyrev, I
    Whelan, C
    Brown, H
    Tang, MX
    Mayeux, R
    ANNALS OF NEUROLOGY, 2001, 49 (06) : 808 - 810
  • [50] Presenilins, amyloid-β and Alzheimer's disease
    Bruce T. Lamb
    Nature Medicine, 1997, 3 : 28 - 29